A UK trial finds that low-dose atropine modestly slows childhood myopia progression and axial eye growth over 2 years without increasing adverse events.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/low-dose-atropine-childhood-myopia-worth-using-2026a1000mqe?src=rss
Author :
Publish date : 2026-07-06 08:58:00
Copyright for syndicated content belongs to the linked Source.